Dr. Kaplan's Revolutionary Death Ray for Kids

The image of a child undergoing modern anticancer treatments is especially jarring—little bald-headed androgynous rascals, so cherubic you can't help but marvel at the cruelty of a world that permits gangly tumors to spread through such innocence, and the heart bleeds at the thought of poisonous chemotherapy wreaking its havoc on their growing bodies.

St. Jude's Children's Hospital has become especially skilled at showcasing such patients in ads to attract donation dollars, but when it comes to matching innocence with the terrifying barbarism of modern anticancer imagery, nobody can hold a candle to little Gordon Isaacs and the 6-million volt Death Ray looming behind him:

Stark images like this can speak a thousand words, but how many of them are true? While the picture speaks of hopeless overkill, of Cold War weaponry, of Lovercraft-like horrors, the reality—at least as goes this pic—is none of these things.

Rather, the photo (taken at Stanford University Hospital in 1957 and now in the public domain) illustrates the first American patient treated with the now-standard linear accelerator (radiotherapy) for retinoblastoma. That patient happened to be little Gordy, and he'd already lost his right eye to the cancer, and a localized tumor was threatening the vision in his left. Instead of putting Gordo under the knife for yet another surgery, his doctor, the great Henry Kaplan, decided to try the accelerator.

The result was a success. Gordon retained the vision in his left eye and as of 1984, the last word I can reliably find for him, he was a healthy adult male with good vision in one eye living somewhere in the vicinity of the San Francisco Bay Area. Kaplan's name still carries massive weight in Hodgkin's circles, and rightfully so—before Henry Kaplan, people diagnosed with Hodgkin's Lymphoma were considered lost causes. Today they're often told (appropriately or not) that they're lucky because it's a curable cancer, thanks in great part to Kaplan's pioneering and innovative work.

By Ross Bonander
Blog Category: 

More Articles

More Articles

This article looks at the Non-Hodgkin's Lymphoma survival rate as well as the Non-Hodgkin's Lymphoma mortality rate ....

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

Canine lymphoma is a fairly common cancer in American dogs. The most commonly seen lymphoma in America is a type called Lymphosarcoma, although...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

Marginal zone lymphomas (MZL) are indolent lymphomas that affect the B-cells. The...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

Aggressive Non-Hodgkin’s Lymphomas (NHLs) are fast growing cancers (as opposed to indolent cancers). They involve...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

What causes lymphoma is not well known. DNA mutations may be what causes lymphoma to develop but what triggers these mutations is...

Often the one who makes the first diagnosis of Hodgkin's Lymphoma / Disease is the person affected. There are some...

Lymphedema is abnormal swelling due to the presence of excess lymphatic fluid within the tissues. This swelling occurs when the...

RICE is an acronym for an anti-cancer treatment that expresses a combination chemotherapeutic regimen. This regimen is written variously as "R+ICE...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...